OMEGA-3 FATTY ACID AND DYSLIPIDEMIC AGENT FOR LIPID THERAPY

摘要

PROBLEM TO BE SOLVED: To provide combination products of dyslipidemic agents and omega-3 fatty acids, in particular a combination product that provides a single administration of concentrated amounts of omega-3 fatty acids and a dyslipidemic agent, for example, in a unit dosage.

SOLUTION: The pharmaceutical composition includes a fixed dosage form containing the dyslipidemic agent selected from HMG CoA inhibitors and a solvent system containing the omega-3 fatty acids. The solvent system includes solubilizers other than the omega-3 fatty acids in amounts of less than 50 w/w% based on the total weight of the solvent system.

COPYRIGHT: (C)2012,JPO&INPIT